Oncopeptides AB (publ)
SSE:ONCO.ST
7.264 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||
Current Assets: | ||||||||||
Cash & Cash Equivalents
| 173.407 | 344.515 | 362.187 | 840.255 | 926.186 | 375.617 | 404.05 | 40.251 | 2.293 | 11.966 |
Short Term Investments
| 0.032 | 0.348 | 2.112 | 12.227 | 0 | -0.85 | -0.262 | -0.262 | 0 | 0 |
Cash and Short Term Investments
| 173.407 | 344.515 | 362.187 | 840.255 | 926.186 | 375.617 | 404.05 | 40.251 | 2.293 | 11.966 |
Net Receivables
| 27.068 | 17.268 | 37.998 | 23.229 | 6.976 | 2.456 | 1.189 | 2.963 | 0 | 0.047 |
Inventory
| 2.425 | 0 | 0 | 8.665 | 0 | -2.456 | 71.983 | -2.963 | 0 | 0 |
Other Current Assets
| -0 | 2.251 | -0.001 | 22.65 | 37.726 | 65.699 | -0.001 | 14.018 | -0.001 | 0.979 |
Total Current Assets
| 202.9 | 364.034 | 412.373 | 894.799 | 970.888 | 441.316 | 477.221 | 54.269 | 4.231 | 12.944 |
Non-Current Assets: | ||||||||||
Property, Plant & Equipment, Net
| 34.626 | 20.438 | 24.744 | 38.33 | 17.192 | 2.363 | 2.339 | 1.1 | 0.007 | 0.015 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 1.408 | 1.83 | 2.111 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 1.408 | 1.83 | 2.111 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0.852 | 0.851 | 0.851 | 3.622 | 1.035 | 0.851 | 0.263 | 0.263 | 0 | 0 |
Tax Assets
| 0 | 0 | -0.851 | 8.175 | 2.262 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| -0 | 0 | -26.152 | 0 | 0 | 0 | -0.001 | 0 | 0.164 | 0.163 |
Total Non-Current Assets
| 35.478 | 21.289 | 27.003 | 51.957 | 22.6 | 3.214 | 2.601 | 1.363 | 0.171 | 0.178 |
Total Assets
| 238.378 | 385.323 | 439.376 | 946.756 | 993.488 | 444.53 | 479.822 | 55.633 | 4.402 | 13.123 |
Liabilities & Equity: | ||||||||||
Current Liabilities: | ||||||||||
Account Payables
| 15.025 | 28.219 | 35.702 | 136.135 | 80.986 | 25.27 | 15.681 | 8.731 | 5.115 | 2.568 |
Short Term Debt
| 5.131 | 5.999 | 10.987 | 12.426 | 6.652 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0.579 | 6.778 | 7.025 | 14.24 | 5.478 | 4.056 | 0.954 | 0 | 0.186 | 0 |
Deferred Revenue
| 0.5 | 0 | 128.681 | 197.46 | 77.353 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 24.277 | 51.454 | 49.919 | 8.379 | 0.189 | 88.57 | 44.312 | 20.565 | 1.887 | 2.949 |
Total Current Liabilities
| 44.933 | 85.672 | 225.289 | 354.4 | 165.18 | 113.84 | 59.993 | 29.296 | 7.002 | 5.517 |
Non-Current Liabilities: | ||||||||||
Long Term Debt
| 106.487 | 3.543 | 3.206 | 6.929 | 8.243 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 30.178 | 1.815 | 0.013 | 8.53 | 23.052 | 14.858 | 1.824 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 136.665 | 5.358 | 3.219 | 15.459 | 31.295 | 14.858 | 1.824 | 0 | 0 | 0 |
Total Liabilities
| 181.598 | 91.03 | 228.508 | 369.859 | 196.475 | 128.698 | 61.817 | 29.296 | 7.002 | 5.517 |
Equity: | ||||||||||
Preferred Stock
| 5,355.476 | 2.297 | 0.918 | 1.542 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 10.511 | 10.479 | 8.366 | 7.549 | 6.157 | 4.899 | 4.423 | 2.449 | 2.046 | 1.506 |
Retained Earnings
| -5,365.987 | -5,116.414 | -4,778.463 | -3,348.146 | -1,753.452 | -961.919 | -542.462 | -294.85 | -180.405 | -127.064 |
Accumulated Other Comprehensive Income/Loss
| 46.269 | -2.297 | -0.918 | -1.542 | 0.002 | 0.022 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 10.511 | 5,400.228 | 4,980.965 | 3,917.494 | 2,544.306 | 1,272.83 | 956.044 | 318.738 | 175.759 | 133.163 |
Total Shareholders Equity
| 56.78 | 294.293 | 210.868 | 576.897 | 797.013 | 315.832 | 418.005 | 26.337 | -2.6 | 7.606 |
Total Equity
| 56.78 | 294.293 | 210.868 | 576.897 | 797.013 | 315.832 | 418.005 | 26.337 | -2.6 | 7.606 |
Total Liabilities & Shareholders Equity
| 238.378 | 385.323 | 439.376 | 946.756 | 993.488 | 444.53 | 479.822 | 55.633 | 4.402 | 13.123 |